[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":31509000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_4_FY_USD":-179000.0,"AccruedRoyaltiesCurrent_0_FY_USD":5817000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_FY_USD":158000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":13360000.0,"AssetsFairValueDisclosure_0_FY_USD":306709000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_FY_USD":216000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_FY_USD":11000.0,"OtherLiabilitiesNoncurrent_0_FY_USD":2757000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_FY_USD":306504000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_FY_USD":306709000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4_FY_USD":15963000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_4_FY_USD":23364000.0,"CurrentForeignTaxExpenseBenefit_4_FY_USD":68000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_4_FY_USD":229000.0,"DeferredForeignIncomeTaxExpenseBenefit_4_FY_USD":-42000.0,"DeferredTaxAssetsOperatingLossCarryforwardsDomestic_0_FY_USD":43623000.0,"AvailableForSaleSecuritiesDebtSecurities_0_FY_USD":306709000.0,"DeferredTaxAssetsTaxCreditCarryforwardsResearch_0_FY_USD":13400000.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":-0.035,"EmployeeRelatedLiabilitiesCurrent_0_FY_USD":10951000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":31655000.0,"DeferredIncomeTaxAssetsNet_0_FY_USD":81516000.0,"DeferredIncomeTaxExpenseBenefit_4_FY_USD":6189000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_4_FY_pure":0.002,"ProceedsFromStockOptionsExercised_4_FY_USD":5634000.0,"DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_0_FY_USD":8400000.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_4_FY_pure":0.5,"DeferredIncomeTaxLiabilities_0_FY_USD":4323000.0,"EarningsPerShareDiluted_1_FY_USD":0.15,"InventoryFinishedGoodsNetOfReserves_0_FY_USD":1214000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4_FY_USD":5.53,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_4_FY_shares":763119.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_FY_USD":61613000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_FY_USD":81000.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":13360000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0_FY_USD":2429000.0,"EarningsPerShareDiluted_4_FY_USD":0.42,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":31667000.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_0_FY_USD":4653000.0,"DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_0_FY_USD":1911000.0,"OperatingLeaseLiabilityCurrent_0_FY_USD":2117000.0,"OperatingLeaseLiabilityNoncurrent_0_FY_USD":11497000.0,"OperatingLeasePayments_4_FY_USD":2600000.0,"OperatingLeaseRightOfUseAsset_0_FY_USD":10459000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_FY_pure":0.081,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_4_FY_USD":-102000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_4_FY_USD":68000.0,"OperatingLeaseLiability_0_FY_USD":13614000.0,"OtherComprehensiveIncomeLossTax_4_FY_USD":-24000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_4_FY_USD":346622000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_4_FY_USD":306918000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":248168000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_4_FY_pure":0.51,"ShortTermLeaseCost_4_FY_USD":400000.0,"UnrecognizedTaxBenefits_0_FY_USD":11233000.0,"UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_4_FY_USD":121000.0,"OtherNoncashIncomeExpense_4_FY_USD":-1758000.0,"DeferredTaxAssetsTaxDeferredExpenseOther_0_FY_USD":3279000.0,"OperatingLeaseCost_4_FY_USD":2300000.0,"NumberOfOperatingSegments_4_FY_segment":1.0,"DefinedContributionPlanCostRecognized_4_FY_USD":900000.0,"DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4_FY_pure":0.06,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_4_FY_pure":0.012,"EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4_FY_pure":0.051,"EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_4_FY_pure":0.054,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4_FY_USD":53000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":-12000.0,"NumberOfReportableSegments_4_FY_segment":1.0,"InventoryNoncurrent_0_FY_USD":5091000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_FY_USD":18032000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_FY_USD":5624000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_FY_USD":2557000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_FY_USD":2488000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_FY_USD":2462000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_FY_USD":2611000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_FY_USD":4418000.0,"InventoryWorkInProcessNetOfReserves_0_FY_USD":66000.0,"OtherComprehensiveIncomeLossNetOfTax_4_FY_USD":-10000.0,"ComprehensiveIncomeNetOfTax_4_FY_USD":23327000.0,"PaymentsToAcquireIntangibleAssets_4_FY_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-41499000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":51775000.0,"NetIncomeLoss_1_FY_USD":8190000.0,"NetIncomeLoss_4_FY_USD":23337000.0,"PaymentsToAcquirePropertyPlantAndEquipment_4_FY_USD":1795000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_FY_USD":10089000.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":5634000.0,"PropertyPlantAndEquipmentNet_0_FY_USD":4136000.0,"Revenues_1_FY_USD":67653000.0,"Revenues_4_FY_USD":248168000.0,"StockholdersEquity_0_FY_USD":453266000.0,"CommitmentsAndContingencies_0_FY_USD":null,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.001,"CommonStockSharesAuthorized_0_FY_shares":150000000.0,"DeferredTaxAssetsNet_0_FY_USD":81516000.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-197328000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"LiabilitiesCurrent_0_FY_USD":65936000.0,"Liabilities_0_FY_USD":80190000.0,"AccountsReceivableNetCurrent_0_FY_USD":30036000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_FY_USD":239000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":3407409.0,"Assets_0_FY_USD":533456000.0,"AssetsCurrent_0_FY_USD":409145000.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":61031000.0,"CommonStockSharesIssued_0_FY_shares":54865092.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":533456000.0,"CommonStockSharesOutstanding_0_FY_shares":54865092.0,"CostsAndExpenses_4_FY_USD":220929000.0,"Depreciation_4_FY_USD":1386000.0,"GrossProfit_1_FY_USD":60871000.0,"IncomeTaxExpenseBenefit_4_FY_USD":8318000.0,"IncreaseDecreaseInAccountsReceivable_4_FY_USD":3767000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4_FY_USD":-4068000.0,"InventoryNet_0_FY_USD":1280000.0,"CommonStockValue_0_FY_USD":55000.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4_FY_pure":0.026,"OperatingIncomeLoss_1_FY_USD":10451000.0,"OperatingIncomeLoss_4_FY_USD":27239000.0,"PropertyPlantAndEquipmentGross_0_FY_USD":12164000.0,"AccruedProfessionalFeesCurrent_0_FY_USD":5052000.0,"AdvertisingExpense_4_FY_USD":12600000.0,"FiniteLivedIntangibleAssetsNet_0_FY_USD":21559000.0,"DeferredFederalIncomeTaxExpenseBenefit_4_FY_USD":6076000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_4_FY_USD":155000.0,"DeferredTaxAssetsGross_0_FY_USD":92890000.0,"OtherIncome_4_FY_USD":4416000.0,"DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0_FY_USD":1169000.0,"DeferredTaxLiabilitiesOther_0_FY_USD":2412000.0,"EarningsPerShareBasic_1_FY_USD":0.15,"EarningsPerShareBasic_4_FY_USD":0.43,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":5634000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":54427683.0,"OtherAccruedLiabilitiesCurrent_0_FY_USD":1049000.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":650300000.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":7051000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_FY_USD":2290000.0,"IncreaseDecreaseInInventories_4_FY_USD":2876000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":3759000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.001,"PreferredStockSharesAuthorized_0_FY_shares":20000000.0,"PreferredStockSharesIssued_0_FY_shares":0.0,"PreferredStockSharesOutstanding_0_FY_shares":0.0,"PreferredStockValue_0_FY_USD":0.0,"ResearchAndDevelopmentExpense_4_FY_USD":55577000.0,"SellingGeneralAndAdministrativeExpense_4_FY_USD":140510000.0,"ShareBasedCompensation_4_FY_USD":13360000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4_FY_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4_FY_pure":0.0114,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":55190802.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_FY_USD":8028000.0,"AmortizationOfIntangibleAssets_4_FY_USD":1478000.0,"CurrentFederalTaxExpenseBenefit_4_FY_USD":0.0,"CurrentStateAndLocalTaxExpenseBenefit_4_FY_USD":2061000.0,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":0.263,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_4_FY_pure":0.017,"UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_4_FY_USD":1613000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_FY_USD":11200000.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210211"}]